Taku Furukawa, Yugeesh R Lankadeva, Ian C Baldwin, Pei Chen Connie Ow, Sally Hood, Chin Bin Eap, Antoine Schneider, Laurent A Decosterd, Rinaldo Bellomo
{"title":"Removal of psychotropic drugs by hemoadsorption with the HA380 cartridge.","authors":"Taku Furukawa, Yugeesh R Lankadeva, Ian C Baldwin, Pei Chen Connie Ow, Sally Hood, Chin Bin Eap, Antoine Schneider, Laurent A Decosterd, Rinaldo Bellomo","doi":"10.1159/000547371","DOIUrl":null,"url":null,"abstract":"<p><strong>Introduction: </strong>Psychotropic drug intoxication may require urgent management. Hemoadsorption (HA) may detoxify blood in such cases, but its effect has not been quantified.</p><p><strong>Methods: </strong>We studied in-vivo removal of valproate, quetiapine and escitalopram with HA using the Jafron HA 380 cartridge in six sheep. We measured the removal rate (RR) and clearance (CL) of each agent over time.</p><p><strong>Results: </strong>Mean sorbent-based valproate RR was initially 55.8% (CL 58.2 mL/min), but declined to negligible at 120 min. Mean initial RR for quetiapine was > 90% and remained high (72%) at 4-hours with CL of 87.2 mL/min at 10 minutes and 68.7 mL/min at 240 min. Mean RR of escitalopram exceeded 90 % at 10 minutes and decreased to 66.9 % at 4 hours. The mean CL was 88.0 ml/min at 10 min and 63.2 ml/min at 240 min.</p><p><strong>Conclusion: </strong>HA with the HA380 cartridge achieves effective removal of valproate, quetiapine and escitalopram. For valproate, adsorptive performance progressively declined over the 4-hour treatment period. In contrast, with quetiapine and escitalopram, the function remained substantial for up to 4 hours. Further research is required to optimize HA strategies for these drugs and facilitate clinical translation of HA-based blood detoxification.</p>","PeriodicalId":8953,"journal":{"name":"Blood Purification","volume":" ","pages":"1-17"},"PeriodicalIF":1.8000,"publicationDate":"2025-09-08","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Blood Purification","FirstCategoryId":"3","ListUrlMain":"https://doi.org/10.1159/000547371","RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q3","JCRName":"HEMATOLOGY","Score":null,"Total":0}
引用次数: 0
Abstract
Introduction: Psychotropic drug intoxication may require urgent management. Hemoadsorption (HA) may detoxify blood in such cases, but its effect has not been quantified.
Methods: We studied in-vivo removal of valproate, quetiapine and escitalopram with HA using the Jafron HA 380 cartridge in six sheep. We measured the removal rate (RR) and clearance (CL) of each agent over time.
Results: Mean sorbent-based valproate RR was initially 55.8% (CL 58.2 mL/min), but declined to negligible at 120 min. Mean initial RR for quetiapine was > 90% and remained high (72%) at 4-hours with CL of 87.2 mL/min at 10 minutes and 68.7 mL/min at 240 min. Mean RR of escitalopram exceeded 90 % at 10 minutes and decreased to 66.9 % at 4 hours. The mean CL was 88.0 ml/min at 10 min and 63.2 ml/min at 240 min.
Conclusion: HA with the HA380 cartridge achieves effective removal of valproate, quetiapine and escitalopram. For valproate, adsorptive performance progressively declined over the 4-hour treatment period. In contrast, with quetiapine and escitalopram, the function remained substantial for up to 4 hours. Further research is required to optimize HA strategies for these drugs and facilitate clinical translation of HA-based blood detoxification.
期刊介绍:
Practical information on hemodialysis, hemofiltration, peritoneal dialysis and apheresis is featured in this journal. Recognizing the critical importance of equipment and procedures, particular emphasis has been placed on reports, drawn from a wide range of fields, describing technical advances and improvements in methodology. Papers reflect the search for cost-effective solutions which increase not only patient survival but also patient comfort and disease improvement through prevention or correction of undesirable effects. Advances in vascular access and blood anticoagulation, problems associated with exposure of blood to foreign surfaces and acute-care nephrology, including continuous therapies, also receive attention. Nephrologists, internists, intensivists and hospital staff involved in dialysis, apheresis and immunoadsorption for acute and chronic solid organ failure will find this journal useful and informative. ''Blood Purification'' also serves as a platform for multidisciplinary experiences involving nephrologists, cardiologists and critical care physicians in order to expand the level of interaction between different disciplines and specialities.